65,437 trials
Pneumonia, Pneumococcal
Primary: Number of Participants With Solicited Injection-site Adverse Events (AEs) — 317; 314 Participants
Diabetes Mellitus
Primary: Glucose Self-monitoring Adherence — 65; 70; 72 percentage of days
Family · Alzheimer Dementia
Primary: Change in Caregiver Burden and Stress — 40; 18; 32; 18.5 score on a scale
Diabetes
Primary: HbA1c Level — 6.9; 6.4 percentage of glycated hemoglobin
Myelodysplastic Syndromes · Leukemia, Myelomonocytic, Chronic · Leukemia, Myeloid, Acute
Primary: Part A, AUC∞: Area Under the Plasma Concentration-time Curve From Time Zero to Infinity for Pevonedistat Following a Single Dose — 1168.616; 1293.467; 1050.553…
Controlled Feeding Trial · Healthy Eating Index · Red Meat
Primary: Test the Effects of Red and Processed Meat on Aqueous Biomarkers of the Blood Metabolome — 0.87; 0.60; 3.48; 5.66 ratio of day 21 to day 0
Cardiac Arrhythmia
Primary: Baseline Noise Comparison — 19; 46; 31; 463 μV
Attention Deficit Hyperactivity Disorder
Primary: Proportion of Days Covered With Medicine — 0.69 Proportion of days covered with medicine
Non-Eosinophilic Asthma
Primary: The Ability of AVTX-002 to Improve Asthma Control in Subjects With Poorly Controlled Non-eosinophilic Asthma (NEA) Based on the Percentage of Patients Who Experience…
Insulin Resistance
Primary: Linear Relationship Between HOMA-IR and Cognitive Function (R-squared) — 0.205; 0.299; 0.738; 0.0264 R-squared — p=0.162
Presbyopia · Refractive Errors · Eye Diseases
Primary: Percentage of Participants With a ≥ 3-line Improvement in Near Vision and no Loss ≥ 5 Letters Distance Vision — 56.0; 71.4; 5.9 percentage of participants — p=<0.0001
Androgenetic Alopecia
Primary: Mean Change in Terminal Hair Count From Baseline to 16 Weeks — -15.53; 14.26; 18.94; 5.22 Change in total hair counts
Influenza
Primary: Mean Area Under the Viral Load-Time Curve (VL-AUC) After Influenza Viral Challenge — 16.09; 10.70 log[10] copies/milliliter (mL)*hour — p=0.0390
Stoma Site Leakage · Quality of Life · Nurse's Role
Primary: Evaluate Body Assessment Tool Based on the Nurse Evaluation Form — 4.6; 5.1; 4.7 score on a scale
Systemic Lupus Erythematosus
Primary: Percentage of Participants Achieving SLE Responder Index (SRI) Change of 4 (SRI-4) at Week 52 — 64.6; 57.4; 69.7; 66.3 Percentage of participants — p=0.8076